Kewaunee Scientific (NASDAQ:KEQU) Upgraded at StockNews.com

StockNews.com upgraded shares of Kewaunee Scientific (NASDAQ:KEQUFree Report) from a hold rating to a buy rating in a report published on Monday morning.

Kewaunee Scientific Price Performance

Shares of NASDAQ KEQU opened at $41.05 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00. The stock has a fifty day moving average price of $35.91 and a 200 day moving average price of $41.97. Kewaunee Scientific has a 1-year low of $17.12 and a 1-year high of $55.62. The company has a market cap of $117.81 million, a PE ratio of 6.59 and a beta of 0.80.

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) last issued its quarterly earnings results on Wednesday, September 11th. The technology company reported $0.93 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.87% and a net margin of 9.13%. The firm had revenue of $48.39 million during the quarter.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Barclays PLC purchased a new position in Kewaunee Scientific in the third quarter worth $121,000. Geode Capital Management LLC raised its position in Kewaunee Scientific by 8.9% in the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after acquiring an additional 1,941 shares in the last quarter. State Street Corp purchased a new position in Kewaunee Scientific in the third quarter worth $266,000. De Lisle Partners LLP raised its position in Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after acquiring an additional 11,511 shares in the last quarter. Finally, Ritholtz Wealth Management raised its position in Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after acquiring an additional 2,156 shares in the last quarter. Hedge funds and other institutional investors own 32.69% of the company’s stock.

About Kewaunee Scientific

(Get Free Report)

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

Featured Stories

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.